Overdiagnosed and oversupplemented: the iatrogenic rise of vitamin D toxicity
European Journal of Endocrinology · 01.06.2026 · 194 (6) · K21-K25
DOI: 10.1093/ejendo/lvag088 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Endocrinology, online erschienen am 18.05.2026. Verfasst von Aleix B Fabregat-Bolufer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry and Molecular Genetics Department, Biomedical Diagnostic Center (CDB), Hospital Clínic de Barcelona, 08036 Barcelona, Catalonia, Spain. Hauptthemen laut MEDLINE: Vitamin D, Hypercalcemia, Dietary Supplements, Vitamin D Deficiency. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Agencia Estatal de Investigación, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Spanish pharmacovigilance alerts have highlighted vitamin D overdosing. We retrospectively analysed adult serum 25(OH)D results from a Barcelona tertiary hospital (2020-2025), measured using a VDSCP-certified immunoassay. For results >100 ng/mL (250 nmol/L), concomitant calcium, phosphorus, albumin, alkaline phosphatase and parathyroid hormone were retrieved. Hypercalcemia was defined as albumin-corrected calcium >10.5 mg/dL. Among 185 604 results, annual testing increased by 54.1% and median 25(OH)D rose from 25.3 to 28.6 ng/mL. Very high results more than doubled (31 [0.14%] to 108 [0.31%]; n = 393). Calcium was available in 324/393 results, and hypercalcemia occurred in 14/324 (4.3%). Calcifediol was documented in 183/201 (91.0%) hypervitaminosis D patients with available supplementation data and in 12/14 (85.7%) hypercalcemic cases, often in short-interval dosing regimens. Rapid test growth paralleled a rightward shift and expanding high-concentration tail, supporting evidence-based requesting, clearer intermittent-dosing and supplementation instructions, and selective serum calcium surveillance when 25(OH)D is greatly elevated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry and Molecular Genetics Department, Biomedical Diagnostic Center (CDB), Hospital Clínic de Barcelona, 08036 Barcelona, Catalonia, Spain.
- Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, 08036 Barcelona, Catalonia, Spain.
- Pharmacy Department, Division of Medicines, Hospital Clínic de Barcelona, 08036 Barcelona, Catalonia, Spain.
- Centre for Biomedical Research Network on Liver and Digestive Diseases (CIBERehd), 28029 Madrid, Community of Madrid, Spain.
- Biomedicine Department, Faculty of Medicine and Health Sciences, Universitat de Barcelona, 08036 Barcelona, Catalonia, Spain.
ORCID-Profile: Aleix B Fabregat-Bolufer, Carlos Martín-Alonso, Alba Escolà-Rodríguez, Manuel Morales-Ruiz
Förderung
- Agencia Estatal de Investigación
- Instituto de Salud Carlos III
Zitieren
APA
Fabregat-Bolufer, A. B., Martín-Alonso, C., Escolà-Rodríguez, A., & Morales-Ruiz, M. (2026). Overdiagnosed and oversupplemented: the iatrogenic rise of vitamin D toxicity. European Journal of Endocrinology, 194(6), K21-K25. https://doi.org/10.1093/ejendo/lvag088
Vancouver
Fabregat-Bolufer AB, Martín-Alonso C, Escolà-Rodríguez A, Morales-Ruiz M. Overdiagnosed and oversupplemented: the iatrogenic rise of vitamin D toxicity. European Journal of Endocrinology. 2026;194(6):K21-K25. doi:10.1093/ejendo/lvag088
BibTeX
@article{FabregatBolufer2026,
author = {Fabregat-Bolufer, Aleix B and Martín-Alonso, Carlos and Escolà-Rodríguez, Alba and Morales-Ruiz, Manuel},
title = {Overdiagnosed and oversupplemented: the iatrogenic rise of vitamin D toxicity},
journal = {European Journal of Endocrinology},
year = {2026},
volume = {194},
number = {6},
pages = {K21--K25},
doi = {10.1093/ejendo/lvag088}
}
EUVIMED